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Abstract
BACKGROUND. After a primary transluminal coronary angioplasty (PTCA) following AMI (acute myocardial infarction), the 
perfusion defect and LV (left ventricular) function recover/change over a period of time. The analysis immediately after the pro-
cedure may not be true depiction of the exact success of the procedure. There is varying and scanty information available on 
the natural course of changes in these parameters after a successful PTCA. We hypothesized that majority of change occurs 
at 3–4 month period. Hence, we undertook this study on the natural course of recovery/changes occurring in perfusion defect 
size and LV function in first 3 months after primary angioplasty. 
MATERIAL AND METHODS. 30 consecutive cases of first AMI who were taken up for Primary angioplasty were enrolled into 
the study. Resting MPI (Myocardial perfusion imaging) was done within 24–72 hrs of admission using Tc-99m–Tetrofosmin 
and after 10–14 weeks. Analysis of LVEF (left ventricular ejection fraction), summed segmental score and extent of perfusion 
defect was done. Images were processed using autocardiac software of emory tool box and quantification was done using QPS 
(quantitative perfusion SPECT) and QGS (qualitative perfusion SPECT) softwares. 20 segment scoring method was used for 
quantification on bull’s eye images. Student t test (two tailed, dependent) was used to find the significance of study parameters 
on continuous scale within each group. Effect size was computed to find the effect. Pearson correlation between perfusion 
defect and LVEF was performed at acute stage and after 10–14 weeks.
RESULTS. The average acute perfusion defect extent was 19.76 ± 12.89% which after 3 months became 16.79 ± 12.61%. The 
summed segmental score changed from 14.31 ± 10.58 to 11.38 ± 10.03 and LVEF improved from 48.40 ± 13.15% to 53.37 
± 12.8%. There was significant improvement in LVEF from acute setting to 10–14 weeks (p = 0.001). There was significant 
lowering of summed score (p = 0.007). Perfusion defect size showed significant reduction (p = 0.030). Three patients showed 
deterioration in perfusion defect size and in summed score with reduction in LVEF. Four patients had no change in any of 
the parameters. Correlation between perfusion defect and LVEF was strong both at baseline (r = -0.705, p < 0.001) and after 
10–18 weeks (r = -0.766, p < 0.001).
CONCLUSION. The changes we found in 3 months are similar to earlier studies and also to studies using follow up at 6 months 
to 1 year. We feel that 3 months is a good enough time to accurately assess the success of primary angioplasty. 
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Introduction
Restoration of epicardial blood flow after revascularization may 
not be equivalent to restoration of complete myocardial blood flow. 
The microvascular flow also determines the outcome and this flow 
depends on various factors e.g. presence of any microemboli during 
the angioplasty, inflammation and edema of the myocardium due 
to the primary event or prolonged dilatation of vessels impairing 
autoregulation [1]. The perfusion may recover over months. Hence 
it takes time for full recovery to be seen after revascularization. 
Moreover, after the myocardial salvage post revascularization, part 
of the salvaged segment may still be stunned. Stunned myocar-
dium is viable myocardium salvaged by coronary reperfusion that 
exhibits prolonged postischemic dysfunction after reperfusion [2]. 
It could also be due to intermittently reduced blood flow. In addi-
tion there might have been some hibernating myocardium present 
prior to the revascularization procedure. Hibernating myocardium 
is ischemic myocardium supplied by a narrowed coronary artery 
in which ischemic cells remain viable but contraction is chronically 
depressed. This can be reversed by restoring the oxygen sup-
ply [3]. Persistent ischemic dysfunction leads to hibernation. The 
restoration of the full contractile function after the revascularization 
procedure occurs over a period of time. Hence, the functional state 
of LV (left ventricle) and wall motion abnormalities immediately 
after the revascularization may not be true depiction of the exact 
success of the procedure.
Hence, we need to monitor the patient’s status after success-
ful revascularization with methods which evaluate the myocardial 
perfusion and LV function not only within few days but also after 
few months of the salvage procedure to accurately assess the 
success of the procedure. However, patient is curious to know the 
exact improvement/success of the procedure. How early can we 
provide them with this information and accurately prognosticate 
the condition and what is the natural course of changes in perfu-
sion and function after successful revascularization are important 
questions to be answered. The perfusion in the distribution of 
dilated artery has been shown to improve progressively until 
3 months [4]. Many authors have not found any difference in LV 
ejection fraction values in the third and sixth month following AMI 
[5–7]. This makes us hypothesize that majority of the improvement 
occurs in the first 3–4 months. The aim of this study is to evaluate 
the changes occurring in perfusion defect size and LV function in 
the first 3 months after primary angioplasty. The second aim is to 
assess whether 3 months period is good enough to accurately 
evaluate the results of reperfusion.
Material and methods
Study population
Inclusion criteria — patients who were admitted for the first time 
with AMI to coronary care unit in Command hospital Bangalore 
within 12 hours of onset of chest pain and who were taken up for 
primary angioplasty were enrolled into the study. The study duration 
for 30 patients was 18 months. Each patient was observed for total 
duration of 10–14 weeks. Diagnosis of AMI was based on clinical 
criteria, ST segment elevation and angiographically demonstrated 
epicardial artery occlusion. All the vessels involved were stented 
with drug eluting stent. The average time from onset to reperfusion 
was 3–4 hours. Two patients were ballooned at 8 hours and one at 
7 hours of onset of symptoms. As our centre has a fully functional 
24 x 7 cardiac catheterization lab, all the patients admitted with AMI 
and suitable for thrombolysis with lesions suitable for angioplasty 
as recommended in the standard guidelines [8] are treated by 
primary angioplasty. 
Exclusion criteria for this study were pregnancy, history of any 
previous percutaneous intervention, those who had undergone 
coronary artery bypass grafting (CABG), history of any previous MI 
and patients who during the 3-month review were detected to have 
restenosis or new lesions on angiography (angiography was done 
as per cardiologists opinion — either based on symptoms of pa-
tients or detected to have positive stress test). 
The 30 patients who met the above criteria were included in 
the study. Resting myocardial perfusion imaging (MPI) was done 
within 24–72 hours after angioplasty and repeat MPI was done after 
10–14 weeks of angioplasty. The treatment following angioplasty 
was not randomized. The patients were treated as per the decision 
of cardiology team. 
MPI protocol
MPI was done using Siemens dual headed single photon 
emission computed tomography (SPECT) gamma camera (E-cam 
Seimens medical solution, health services, Erlangen, Germany). 
Gated SPECT at rest was done 40 minutes after injection of 10 mci 
of Tc-99m Tetrofosmin (Myoview GE healthcare, Buckinghamshire, 
UK). Low energy high resolution collimator (LEHR), with the 2 de-
tectors configured at 76 degrees, were used with step and shoot 
with 32 views, 30 seconds per projection, gating synchronization 
with R wave, 8 frames per cardiac cycle, energy window 20% over 
140 Kev photopeak, 64 x 64 matrix and patient in supine posi-
tion. Reconstruction was performed with filtered back projection 
method using Butterworth filter. Images were further processed 
using auto cardiac software of Emory Tool Box and quantitative 
parameters and scoring was done using QPS (quantitative perfu-
sion SPECT) and QGS (quantitative gated SPECT) softwares of 
cedars cardiac quantification with e-soft Jan 2002. Percentage 
of defect was calculated using the software. 20 segment scoring 
method was used for quantification on polar maps in relation to the 
activity distribution in healthy, gender-stratified, reference popula-
tions for the same LV region. The segments were scored on a 5 
point scale [9]. 0 — normal perfusion; 1 — mild perfusion defect; 
2 — moderate defect; 3 — severe defect and 4 — no perfusion. 
LVEF was calculated by gated SPECT using QGS soft ware. All 
the imaging was done by the same team with the same machine 
and application. 
Statistical analysis
Statistical methods: Descriptive statistical analysis has been 
carried out in the study. Results on continuous measurements are 
presented on Mean ± SD (Min-Max) and results on categorical 
measurements are presented in number (%). Significance is as-
sessed at 5% level of significance. Student t test (two tailed, de-
pendent) was used to find the significance of study parameters on 
continuous scale within each group. Effect size has been computed 
to find the effect. Pearson correlation between extent and LVEF (Left 
Ventricular Ejection Fraction) has been performed at acute stage 
and after 3 months.
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Clearance from ethical committee of Command hospital of 
Rajiv Gandhi university of health sciences Bangalore and written 
informed consent for the patients were obtained for the study.
Classification of Correlation Co-efficient (r)
Up to 0.1  Trivial Correlation
0.1–0.3  Small Correlation
0.3–0.5  Moderate Correlation
0.5–0.7  Large Correlation
0.7–0.9  V. Large Correlation
0.9–1.0 Nearly Perfect correlation
1 Perfect correlation
Significant figures 
+ Suggestive significance (p value: 0.05 < p < 0.10)
* Moderately significant (p value:0.01 < p ≤ 0.05)
** Strongly significant (p value: p ≤ 0.01)
Statistical software: The Statistical software namely SAS 9.2, 
SPSS 15.0, Stata 10.1, MedCalc 9.0.1, Systat 12.0 and R environ-
ment ver.2.11.1 were used for the analysis of the data and Microsoft 
word and Excel have been used to generate graphs, tables.
Results
The demographic characteristics of the 30 patients are as shown 
in Table 1. There were 27 males and 3 females, majority (66.7%) 
were in age group of 40 to 60. 60% of patients were hypertensive, 
50% were smokers and 30% had type-2 diabetes mellitus. Out of 
the total 30 cases, 66.7% patients (n = 20) suffered from anterior 
wall MI (AWMI), 2% (n = 2) antero-septal wall MI (ASWMI), one case 
had inferolateral wall MI and 23.3% patients (n = 7) had inferior wall 
MI (IWMI) (Table 2). 23 patients had single vessel disease — 18 left 
anterior descending artery (LAD), 4 right coronary artery (RCA) and 
1 left circumflex artery (LCX). 7 patients had double vessel disease 
(Table 3). 29 cases achieved Thrombolysis in Myocardial Infarction 
Trial-3 (TIMI-3) flow and in one case TIMI-2 flow was achieved. 
The average time to reperfusion was 3–4 hours (Table  4). Two 
patients were revascularized at 8 hours and 1 at 7 hours of onset 
of symptoms. Analysis of LVEF, summed rest score (SRS) and 
extent of perfusion defect in acute setting and after 10–14 
weeks was done (Table 5 and Fig. 1, 2 and 3). The average acute 
perfusion defect extent in the whole group was 19.76 ± 12.89% 
which after 3 months became 16.79 ± 12.61%. The summed 
segmental score changed from 14.31 ± 10.58 to 11.38 ± 10.03 
and LVEF improved from 48.40 ± 13.15% to 53.37 ± 12.8%. There 
was significant improvement of LVEF from acute setting during the 
next 10–14 weeks (p = 0.001). There was significant lowering of 
SRS (P = 0.007). Perfusion defect size showed significant reduction 
(P = 0.030). Three patients showed worsening in perfusion defect 
size and in summed score with reduction in LVEF. One of these 
three patients was 60 year old male with AWMI, who was reperfused 
8 hours post AMI and symptom presentation, second one was 40 
years old male with AWMI reperfused at 6 hours and the third one 
was 67 years old male with AWMI reperfused after 7 hours. In these 
three patients the size of perfusion defect increased from 27 to 
30%, 25 to 30% and 27 to 38% respectively. In four patients we 
did not observe any change in parameters. Correlation between 
perfusion defect and LVEF overall was strong both at baseline 
studies (r = -0.705, p < 0.001) and after 10–18 weeks of revascu-
larization (r = -0.766, p < 0.001) (Fig. 4 and 5).
Table 1. Demographic data
VARIABLE n or mean
Age 50.07 ± 10.01
Men 27 (90%)
Smokers 15 (50%) F-0
Hypertension 18 (60%) F-3
Diabetes 09 (30%) F-2
Previous CABG 0
Previous angina 03 (10%) F-0
Time of reperfusion (hours)
1–2 5 (16.7%)
3–4 13 (43.3%) F-1 
5–6 9 (30%) F-1
7–8 3 (10%) F-1
F — no. of females; CABG — coronary artery bypass grafting
Table 2. Infarct region
Diagnosis Number of patients 
(n=30)
%
ASWMI 2 6.6
AWMI 20 66.7
INFEROLAT MI 1 3.3
IWMI 7 23.3
ASWMI — antero-septal wall myocardial infarction; AWMI — anterior wall myocardial 
infarction; INFEROLAT MI — inferolateral wall myocardial infarction; IWMI — inferior wall 
myocardial infarction
Table 3. Culprit Vessel
Artery Number of patients 
(n = 30)
%
LAD 18 60.0
LAD/LCX 2 6.7
LAD/RCA 1 3.3
LCX 1 3.3
LCX/LAD 1 3.3
RCA 4 13.3
RCA/LAD 1 3.3
RCA/LCX 2 6.7
LAD — left anterior descending; LCX — left circumflex; RCA — right coronary artery
Table 4. Time to reperfusion in hours
Time to reperfusion 
(hr)
Number of patients 
(n = 30)
%
1–2 5 16.7
3–4 13 43.3
5–6 9 30.0
7–8 3 10.0
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Discussion 
Timely reperfusion is the mainstay of treatment of ST segment 
elevation myocardial infarction (STEMI) [10–12]. The TIMI flow 
achieved is an important prognostic marker for in-hospital mortality 
and clinical outcome 6 months post MI [13]. Myocardial perfusion 
and LVEF may be abnormal despite restoration of TIMI 3 flow 
[14–17]. These two indices (myocardial perfusion defect and LVEF) 
change with time after reperfusion and both of these are important 
predictors of mortality [18, 19].
 The changes in myocardial perfusion and function after suc-
cessful reperfusion are not predictable and vary from patient to 
patient. A lot of physiological and pathological factors come into 
play. There is scanty and variable information available regarding 
the course of changes in perfusion defect size and LV function after 
primary angioplasty. There is still search for an ideal reperfusion 
marker, especially nowadays with improvements in the technique, 
usage of drug eluting stents and low restenosis rates [20, 21]. Some 
earlier studies have revealed that remodeling and changes in LV 
function continues beyond 6months [22]. Whereas other studies 
Table 5. Summed score, Extent of defect and LVEF at 1–3 days and at 10–14 weeks
Variables Acute After 3 months P value Effect size
LVEF% 48.40 ± 13.15 53.37 ± 12.86 0.001** 0.38(S)
SUMMED SCORE 14.31 ± 10.58 11.38 ± 10.03 0.007** 0.28(S)
EXTENT OF DEFECT 19.76 ± 12.89 16.79 ± 12.61 0.030* 0.23(S)
*Moderately significant (P value: 0.01 < P ≤ 0.05); **Strongly significant (P value: P ≤ 0.01); Average change in ejection fraction: 5.26%, Average change in summed score: 26%; VEF — left 
ventricular ejection fraction
Figure 1. Showing temporal change in LVEF from first MPI to second 
MPI. EF 1 is at 1–3 days and EF2 is at 10–14 weeks. LVEF — left 
ventricular ejection fraction
Figure 2. Temporal change in summed segmental score
Figure 3. Temporal change in perfusion defect size
Figure 4. Correlation between LVEF and perfusion defect in the acute 
setting. LVEF — left ventricular ejection fraction
Figure 5. Correlation between LVEF and perfusion defect (extent) after 
3 months. LVEF — left ventricular ejection fraction
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have negated this fact and concluded that LVEF does not change 
after few days to few weeks of reperfusion only the perfusion defect 
might change [23]. 
Now it is well known that myocardial stunning in the region of 
infarction may persist for weeks to months after restoration of blood 
flow [4]. Although these segments are underfunctioning, they are 
still viable and well perfused as seen by uptake of Sestamibi/Tetro-
fosmin. When slowly the cellular function restores, there is further 
improvement in LVEF. In addition, the presence of hibernating 
myocardium affects the size of the perfusion defect as detected 
by Sestamibi scan because Sestamibi uptake is a function of 
blood flow as well as viability [24]. Hence the under perfused but 
viable myocardium may not be differentiated from scar. The slow 
restoration of the microvascular function improves the perfusion 
gradually and leads to reduction in perfusion defect size as well 
as restoration of function. Also, there may be an inherent property 
of infarct to shrink in days to weeks owing to edema resorption and 
phagocytation of dead myocardial cells in early stage and later 
collagen production and contraction [25].
Christian et al. in their study of 84 consecutive patients of AMI 
who were treated with reperfusion therapy, did MPI Sestamibi study 
in the acute stage and at discharge and radionuclide Ventriculog-
raphy at discharge and at 6 weeks. They reported that 25% pa-
tients with AMI had stunned myocardium and they had lower LVEF 
than expected of perfusion defect size at hospital discharge and 
these patients showed a late increase in LVEF after 6 weeks. They 
also found out that 18% of patients had drop in LVEF and they are 
classified as mismatch-hyperkinetic group in which the myocardium 
is hyperkinetic initially (outside the infarct zone) and settles down 
later. They explained it on the basis of compensatory hyperkinesia 
likely to be due to fluctuations in catecholamine release [26, 27]. 
Hence there are many factors which affect the progress of 
perfusion defect size and LVEF after reperfusion therapy in pa-
tients of AMI. Understanding the natural course of evolution of size 
of infarction and LVEF is important. How early can we do MPI study 
to accurately assess the results of reperfusion and prognosticate 
the illness was the question we wanted to study. We evaluated the 
changes in resting MPI at two points of time: 1–3 days’ after reperfu-
sion and 10 to 14 weeks after reperfusion. Analysis of LVEF, summed 
rest score (SRS) and extent of perfusion defect in acute setting and 
after 10–14 weeks was done. The average acute perfusion defect 
extent was 19.76 ± 12.89% which after 3 months (on second 
MPI at 10–14 weeks post primary PCI) became 16.79 ± 12.61%. 
The score changed from 14.31 ± 10.58 to 11.38 ± 10.03 and 
LVEF improved from 48.40 ± 13.15% to 53.37 ± 12.8%. Hence 
there was significant improvement in LVEF from acute setting to 
after 10–14 weeks (p = 0.001). There was significant lowering of 
summed rest score (p = 0.007). Perfusion defect showed signifi-
cant reduction (p = 0.030). Three patients showed deterioration in 
perfusion defect size and in summed score with reduction in LVEF. 
On detailed analysis, it was evident that these were late present-
ers. Castro et al. analyzed the perfusion defect, LV function and LV 
volumes at baseline (preprocedural), 72 hours and 3 months after 
treatment, and they reported that there were no changes between 
the baseline studies and performed after 72 hours in LV function. 
However, a significant increase of LVEF was found 3 months after 
treatment (baseline LVEF of 40±13 at 3 months (50±10%, 
p < 0.05). The perfusion defect size showed significant reduction 
at 72 hours and further reduced after 3 months. They expressed 
this as myocardial salvage percentage (30% at 72 hours which 
increased to 65% at 3 months). Hence, they concluded that the 
actual favorable effect in LV function and perfusion defect size 
takes 3 months [21]. Although we did not do the MPI prior to revas-
cularization procedure due to logistic constraints, our findings are 
similar to the above study. Ottervanger et al. studied changes in 
LVEF in patients treated with primary angioplasty. LV ejection fraction 
was measured by radionuclide ventriculography on the 4th day after 
primary angioplasty and was repeated after 6 months. He found 
the mean relative improvement in LVEF was 6% [19]. In our study 
the mean improvement in LVEF was 5.3% after 3 months itself. 
Hence, maximum improvement probably occurs by 3 months itself. 
Hence, we feel that for accurate estimation of disease status and 
quantifying results; MPI at 3 months may be preferable. 
LVEF has been used as marker for prognostication of MI. Only 
LVEF being the end point for prognostication has limitations. It 
is affected by many factors like therapy with Angiotensin convert-
ing enzyme (ACE) inhibitors and Beta blockers and there is natural 
tendency of the LV to improve in high proportion of cases after MI. 
Hence infarct size is also important parameter to be followed up 
[28, 29]. To evaluate both these parameters MPI is the best modality.
In our study correlation between perfusion defect and LVEF 
was strong both at baseline (r = -0.705, p < 0.001) and after 10–18 
weeks (r = -0.766, p < 0.001). We found a consistent relation be-
tween the size of the perfusion defect and the LVEF, which is like 
what others have reported [19, 30]. Furthermore, we found the initial 
perfusion defect correlated to both summed score and LV ejection 
fraction after 3 months, which might be useful for identifying the 
patients at risk of LV remodelling. Kaltoft et al. in their study of 19 
patients with AMI where they did Tc-99m SESTAMIBI SPECT imag-
ing immediately after revascularization and after 3 months showed 
that the results of the acute imaging correlated significantly with the 
final infarct size, LV volume and LV function 3 months later. They 
concluded that the method holds the potential of risk stratifying 
patients immediately after revascularization [18]. 
Halvorsen et al. in their study of 100 consecutive patients who 
were treated with primary angioplasty for acute ST-elevation myocar-
dial infarction, determined LVEF by radionuclide ventriculography 
before discharge, after 6 weeks and after 20 months. Infarct size 
was assessed by technetium 99m-tetrofosmin SPECT at rest at 
1 week, after 6 weeks and after 20 months. Mean LVEF was 56% at 
discharge, 55% after 6 weeks and 57% after 20 months of follow-up. 
After 1 week, a mean perfusion defect of 19% was measured by 
SPECT. After 6 weeks and 20 months of follow-up, the mean per-
fusion defects extent were reduced to 14% (p < 0.001) and 15%, 
respectively. Hence, they concluded that LVEF does not change 
after 1 week of revascularization procedure but perfusion defect 
changes over long time [23]. However most of the other stud-
ies have different results and LVEF does change over time. The 
changes in LVEF we found after 3 months are similar to earlier 
studies [21, 31] and also to studies using follow up at 6 months to 
1 year [19, 32–34]. 
Conclusion
This study of 30 primary angioplasty patients adds further 
information to the pre-existing limited knowledge about early 
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changes occurring in the LV myocardium post primary angio-
plasty. It shows clearly that the perfusion defect size and LVEF 
measured 1–3 days after revascularization in patients of AMI are 
not accurate depiction of the results of the procedure. We feel that 
3 months is a good enough time to accurately assess the suc-
cess of the procedure.
Limitations 
1. We did the first MPI 1–3 days after the primary angioplasty, if 
some improvement occurred in that period then we might be 
underestimating the actual benefit of revascularization. 
2. We have not followed up 4 months and beyond hence cannot 
comment on prognostic importance.
3. Sample size was restricted to study duration.
4. There are so many other factors e.g. drugs received by the 
patient, which have impact on the recovery of LVEF and remod-
elling process which we have not studied. Treatment was not 
randomized; all the patients were treated by the decision of 
the cardiologist.
5. We adopted the 20 segment scoring method on polar 
maps due to lack of availability of 17 segment scoring software 
in our system. The 17 segment model is recommended as it 
provides best agreement with other imaging modalities and 
anatomical data [35].
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